Some studies have shown that proinflammatory responses presented as increased receptor activator for nuclear factor kappa-B ligand (RANKL) and decreased osteoprotegerin (OPG) in peripheral blood could contribute to the bone loss and osteoporosis patients with RA [10–12]. The gene discussed is TNFSF11; the disease is osteoporosis.